PeopleBio, Inc. (KOSDAQ:304840)
South Korea flag South Korea · Delayed Price · Currency is KRW
561.00
-9.00 (-1.58%)
At close: Jul 31, 2026

PeopleBio Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-14,900-15,714-10,913-16,035-14,303-4,697
Depreciation & Amortization
1,3211,7471,6921,5651,282734.08
Loss (Gain) From Sale of Assets
2.42.4---17.65-5.17
Asset Writedown & Restructuring Costs
5,9815,98163.62---
Loss (Gain) From Sale of Investments
-1,103-1,108392.52395.43--
Loss (Gain) on Equity Investments
472.5758.25988.33934.89835.96380.5
Provision & Write-off of Bad Debts
189.84100.8384.73---
Other Operating Activities
2,5442,157-1,58061.432,299-2,450
Change in Accounts Receivable
382.67647.4223.68-1,502-1,553179.63
Change in Inventory
-81.17-304.97-564.74-1,877-214-156.09
Change in Accounts Payable
238.05242.04-104.56-156.63259.4-157.08
Change in Other Net Operating Assets
-535.22307.88-1,194331.87-2,563-661.94
Operating Cash Flow
-5,487-5,183-10,911-16,282-13,975-6,833
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-213.61-213.61-78.6-719.15-1,267-1,355
Sale of Property, Plant & Equipment
7272--33.2529
Cash Acquisitions
-6.75-6.75---25.73
Sale (Purchase) of Intangibles
-108.12-110.17-36.14-41.08-73.12-35.3
Investment in Securities
3,8405,536-578.292,967-10,300-2,415
Other Investing Activities
85.676.6918.83-890.9364.94-217.79
Investing Cash Flow
3,6695,354-674.21,316-11,542-3,968

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-110.9514,850--31,000
Long-Term Debt Repaid
--1,464-2,694-27,048-684.16-1,333
Net Debt Issued (Repaid)
398.19-1,35312,156-27,048-684.1629,667
Issuance of Common Stock
3,202--29,6061,03612,992
Repurchase of Common Stock
----26.02--
Other Financing Activities
---0-518.45-1.75691.99
Financing Cash Flow
3,601-1,35312,1562,014350.0843,351

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Miscellaneous Cash Flow Adjustments
-0--00--
Net Cash Flow
1,783-1,182570.56-12,952-25,16632,550

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-5,701-5,396-10,990-17,001-15,242-8,188
Free Cash Flow Growth
------
Free Cash Flow Margin
-198.55%-189.30%-434.27%-381.80%-342.91%-1418.84%
Free Cash Flow Per Share
-260.56-247.98-505.52-1025.76-1041.91-510.46
Levered Free Cash Flow
-7,149-2,761-56.87-28,889-13,3789,824
Unlevered Free Cash Flow
-5,364-1,074532.67-27,390-11,51610,532

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
236.94158.24184.05251.37206.88106.75
Cash Income Tax Paid
--2.44-22.45-16.0654.655.68
Change in Working Capital
4.34892.35-1,639-3,204-4,070-795.47